TY - JOUR
T1 - Efficient transduction of 11 poly-arginine peptide in an ischemic lesion of mouse brain
AU - Gotanda, Yuki
AU - Wei, Fan Yan
AU - Harada, Hideki
AU - Ohta, Keisuke
AU - Nakamura, Kei Ichiro
AU - Tomizawa, Kazuhito
AU - Ushijima, Kazuo
N1 - Funding Information:
This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Japan Society for the Promotion of Science (JSPS) through its “Funding Program for Next Generation World-Leading Researchers.”
Publisher Copyright:
© 2014 National Stroke Association.
PY - 2014/9/1
Y1 - 2014/9/1
N2 - Direct intracellular delivery of intact proteins has been successfully achieved by tagging cell-penetrating peptide (CPP), which consists of short positively charged amino acids, such as 11 poly-arginine (11R); however, in vivo delivery of the proteins to the brain has remained challenging because it is unclear whether CPP would enable proteins to cross the blood-brain barrier (BBB). In this study, we conducted an in vivo kinetic study to investigate the efficiency of 11R-mediated peptide delivery in the normal and ischemic brain. The 11R was observed in the microvessels and neurons surrounding the microvessels throughout the brain 1 hour after systemic administration, but the signal of the peptide was faint after 2 hours. In a transient middle cerebral artery occlusion mouse model, 11R was markedly enhanced and remained detectable in the cells on the ipsilateral side for as long as 8 hours after administration compared with the contralateral side. These results suggest that 11R is capable of in vivo delivery to the brain by passing through the BBB. Furthermore, 11R-mediated protein transduction could be used for the delivery of therapeutic molecules in cerebral ischemia.
AB - Direct intracellular delivery of intact proteins has been successfully achieved by tagging cell-penetrating peptide (CPP), which consists of short positively charged amino acids, such as 11 poly-arginine (11R); however, in vivo delivery of the proteins to the brain has remained challenging because it is unclear whether CPP would enable proteins to cross the blood-brain barrier (BBB). In this study, we conducted an in vivo kinetic study to investigate the efficiency of 11R-mediated peptide delivery in the normal and ischemic brain. The 11R was observed in the microvessels and neurons surrounding the microvessels throughout the brain 1 hour after systemic administration, but the signal of the peptide was faint after 2 hours. In a transient middle cerebral artery occlusion mouse model, 11R was markedly enhanced and remained detectable in the cells on the ipsilateral side for as long as 8 hours after administration compared with the contralateral side. These results suggest that 11R is capable of in vivo delivery to the brain by passing through the BBB. Furthermore, 11R-mediated protein transduction could be used for the delivery of therapeutic molecules in cerebral ischemia.
KW - Protein transduction
KW - brain
KW - ischemia
KW - poly-arginine
UR - http://www.scopus.com/inward/record.url?scp=84908150575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908150575&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2014.02.027
DO - 10.1016/j.jstrokecerebrovasdis.2014.02.027
M3 - Article
C2 - 25081308
AN - SCOPUS:84908150575
SN - 1052-3057
VL - 23
SP - 2023
EP - 2030
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 8
ER -